vs
欧加隆（OGN）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
欧加隆的季度营收约是RXO, Inc.的1.0倍（$1.5B vs $1.5B），RXO, Inc.净利率更高（-3.1% vs -13.6%，领先10.5%），欧加隆同比增速更快（-5.3% vs -11.9%），欧加隆自由现金流更多（$96.0M vs $-9.0M），过去两年RXO, Inc.的营收复合增速更高（26.8% vs -3.6%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
OGN vs RXO — 直观对比
营收规模更大
OGN
是对方的1.0倍
$1.5B
营收增速更快
OGN
高出6.5%
-11.9%
净利率更高
RXO
高出10.5%
-13.6%
自由现金流更多
OGN
多$105.0M
$-9.0M
两年增速更快
RXO
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.5B |
| 净利润 | $-205.0M | $-46.0M |
| 毛利率 | 49.2% | — |
| 营业利润率 | -9.8% | -2.9% |
| 净利率 | -13.6% | -3.1% |
| 营收同比 | -5.3% | -11.9% |
| 净利润同比 | -288.1% | -84.0% |
| 每股收益（稀释后） | $-0.78 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNRXO
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.6B | $930.0M | ||
| Q1 24 | $1.6B | $913.0M |
净利润OGNRXO
| Q4 25 | $-205.0M | $-46.0M | ||
| Q3 25 | $160.0M | $-14.0M | ||
| Q2 25 | $145.0M | $-9.0M | ||
| Q1 25 | $87.0M | $-31.0M | ||
| Q4 24 | $109.0M | $-25.0M | ||
| Q3 24 | $359.0M | $-243.0M | ||
| Q2 24 | $195.0M | $-7.0M | ||
| Q1 24 | $201.0M | $-15.0M |
毛利率OGNRXO
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
营业利润率OGNRXO
| Q4 25 | -9.8% | -2.9% | ||
| Q3 25 | 15.2% | -0.5% | ||
| Q2 25 | 14.4% | — | ||
| Q1 25 | 6.7% | -2.1% | ||
| Q4 24 | 8.1% | -1.4% | ||
| Q3 24 | 13.1% | -1.9% | ||
| Q2 24 | 14.6% | — | ||
| Q1 24 | 14.5% | -1.3% |
净利率OGNRXO
| Q4 25 | -13.6% | -3.1% | ||
| Q3 25 | 10.0% | -1.0% | ||
| Q2 25 | 9.1% | -0.6% | ||
| Q1 25 | 5.8% | -2.2% | ||
| Q4 24 | 6.8% | -1.5% | ||
| Q3 24 | 22.7% | -23.4% | ||
| Q2 24 | 12.1% | -0.8% | ||
| Q1 24 | 12.4% | -1.6% |
每股收益（稀释后）OGNRXO
| Q4 25 | $-0.78 | $-0.28 | ||
| Q3 25 | $0.61 | $-0.08 | ||
| Q2 25 | $0.56 | $-0.05 | ||
| Q1 25 | $0.33 | $-0.18 | ||
| Q4 24 | $0.42 | $-0.17 | ||
| Q3 24 | $1.38 | $-1.81 | ||
| Q2 24 | $0.75 | $-0.06 | ||
| Q1 24 | $0.78 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $17.0M |
| 总债务越低越好 | $8.6B | $387.0M |
| 股东权益账面价值 | $752.0M | $1.5B |
| 总资产 | $12.9B | $3.3B |
| 负债/权益比越低杠杆越低 | 11.49× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资OGNRXO
| Q4 25 | $574.0M | $17.0M | ||
| Q3 25 | $672.0M | $25.0M | ||
| Q2 25 | $599.0M | $18.0M | ||
| Q1 25 | $547.0M | $16.0M | ||
| Q4 24 | $675.0M | $35.0M | ||
| Q3 24 | $763.0M | $55.0M | ||
| Q2 24 | $704.0M | $7.0M | ||
| Q1 24 | $575.0M | $7.0M |
总债务OGNRXO
| Q4 25 | $8.6B | $387.0M | ||
| Q3 25 | $8.8B | $387.0M | ||
| Q2 25 | $8.9B | $387.0M | ||
| Q1 25 | $9.0B | $387.0M | ||
| Q4 24 | $8.9B | $351.0M | ||
| Q3 24 | $8.7B | $352.0M | ||
| Q2 24 | $8.7B | $370.0M | ||
| Q1 24 | $8.7B | $351.0M |
股东权益OGNRXO
| Q4 25 | $752.0M | $1.5B | ||
| Q3 25 | $906.0M | $1.6B | ||
| Q2 25 | $733.0M | $1.6B | ||
| Q1 25 | $542.0M | $1.6B | ||
| Q4 24 | $472.0M | $1.6B | ||
| Q3 24 | $493.0M | $1.7B | ||
| Q2 24 | $144.0M | $579.0M | ||
| Q1 24 | $48.0M | $582.0M |
总资产OGNRXO
| Q4 25 | $12.9B | $3.3B | ||
| Q3 25 | $13.6B | $3.2B | ||
| Q2 25 | $13.5B | $3.2B | ||
| Q1 25 | $13.2B | $3.3B | ||
| Q4 24 | $13.1B | $3.4B | ||
| Q3 24 | $12.8B | $3.4B | ||
| Q2 24 | $12.2B | $1.8B | ||
| Q1 24 | $11.9B | $1.8B |
负债/权益比OGNRXO
| Q4 25 | 11.49× | 0.25× | ||
| Q3 25 | 9.74× | 0.24× | ||
| Q2 25 | 12.14× | 0.24× | ||
| Q1 25 | 16.52× | 0.24× | ||
| Q4 24 | 18.81× | 0.22× | ||
| Q3 24 | 17.75× | 0.21× | ||
| Q2 24 | 60.11× | 0.64× | ||
| Q1 24 | 181.54× | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $96.0M | $-9.0M |
| 自由现金流率自由现金流/营收 | 6.4% | -0.6% |
| 资本支出强度资本支出/营收 | 3.0% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $538.0M | $-8.0M |
8季度趋势，按日历期对齐
经营现金流OGNRXO
| Q4 25 | $141.0M | $7.0M | ||
| Q3 25 | $264.0M | $23.0M | ||
| Q2 25 | $220.0M | $23.0M | ||
| Q1 25 | $75.0M | $-2.0M | ||
| Q4 24 | $390.0M | $-7.0M | ||
| Q3 24 | $141.0M | $-7.0M | ||
| Q2 24 | $332.0M | $-5.0M | ||
| Q1 24 | $76.0M | $7.0M |
自由现金流OGNRXO
| Q4 25 | $96.0M | $-9.0M | ||
| Q3 25 | $218.0M | $9.0M | ||
| Q2 25 | $181.0M | $9.0M | ||
| Q1 25 | $43.0M | $-17.0M | ||
| Q4 24 | $335.0M | $-19.0M | ||
| Q3 24 | $99.0M | $-18.0M | ||
| Q2 24 | $300.0M | $-16.0M | ||
| Q1 24 | $30.0M | $-4.0M |
自由现金流率OGNRXO
| Q4 25 | 6.4% | -0.6% | ||
| Q3 25 | 13.6% | 0.6% | ||
| Q2 25 | 11.4% | 0.6% | ||
| Q1 25 | 2.8% | -1.2% | ||
| Q4 24 | 21.0% | -1.1% | ||
| Q3 24 | 6.3% | -1.7% | ||
| Q2 24 | 18.7% | -1.7% | ||
| Q1 24 | 1.8% | -0.4% |
资本支出强度OGNRXO
| Q4 25 | 3.0% | 1.1% | ||
| Q3 25 | 2.9% | 1.0% | ||
| Q2 25 | 2.4% | 1.0% | ||
| Q1 25 | 2.1% | 1.0% | ||
| Q4 24 | 3.5% | 0.7% | ||
| Q3 24 | 2.7% | 1.1% | ||
| Q2 24 | 2.0% | 1.2% | ||
| Q1 24 | 2.8% | 1.2% |
现金转化率OGNRXO
| Q4 25 | — | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 1.70× | — | ||
| Q1 24 | 0.38× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OGN
暂无分部数据
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
